BioXcel Therapeutics

Filed a patent for "dexmedetomidine treatment regimens" on Fri, June 23, 2023

Filed a patent for "dexmedetomidine treatment regimens" on Sun, June 25, 2023

Filed a patent for "novel approach for treatment of cancer using immunomodulation" on Wed, January 18, 2023

Filed a patent for "methods for treating depressive states" on Fri, April 7, 2023

Filed a patent for "methods for treating depressive states" on Mon, May 15, 2023

Filed a patent for "non-sedating dexmedetomidine treatment regimens" on Thu, August 22, 2024

Filed a patent for "non-sedating dexmedetomidine treatment regimens" on Thu, July 25, 2024

Filed a patent for "non-sedating dexmedetomidine treatment regimens" on Thu, August 1, 2024

Filed a patent for "use of sublingual dexmedetomidine for the treatment of agitation" on Thu, August 1, 2024

Filed a patent for "non-sedating dexmedetomidine treatment regimens" on Thu, July 25, 2024

Filed a patent for "methods for treating agitation in community settings" on Sun, September 11, 2022

Filed a patent for "predictive biomarkers for responsiveness to dpp inhibitors in cancers" on Thu, November 3, 2022

Filed a patent for "use of sublingual dexmedetomidine for the treatment of agitation" on Thu, March 23, 2023

Filed a patent for "use of sublingual dexmedetomidine for the treatment of agitation" on Thu, March 16, 2023

Filed a patent for "non-sedating dexmedetomidine treatment regimens" on Thu, April 20, 2023

Filed a patent for "film formulations containing dexmedetomidine and methods of producing them" on Thu, May 4, 2023

Filed a patent for "approach for treatment of cancer via immunomodulation by using talabostat" on Thu, January 4, 2024

Filed a patent for "non-sedating dexmedetomidine treatment regimens" on Thu, January 12, 2023

Filed a patent for "predictive and diagnostic methods for prostate cancer" on Thu, July 20, 2023

Filed a patent for "use of sublingual dexmedetomidine for the treatment of agitation" on Thu, July 13, 2023

Filed a patent for "non-sedating dexmedetomidine treatment regimens" on Thu, March 23, 2023

Filed a patent for "treatment of bipolar disorders and psychosis using dexmedetomidine hydrochloride" on Thu, January 25, 2024

Filed a patent for "methods for treating agitation in community settings" on Wed, May 24, 2023

Filed a patent for "non-sedating dexmedetomidine treatment regimens" on Thu, October 26, 2023

Filed a patent for "film formulations containing dexmedetomidine and methods of producing them" on Thu, December 7, 2023